Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Martin McLaughlin

6PUBLICATIONS

32CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Mar 03, 2026

Effects of oncolytic immunotherapy with RP1 (vusolimogene oderparepvec) on immune cells mediate responsiveness to anti-PD-1 via STING-mediated interferon signaling.

Victoria Roulstone, Joan Kyula, Elizabeth Appleton

|Dec 12, 2024

CXCL12-Targeted Immunomodulatory Gene Therapy Reduces Radiation-Induced Fibrosis in Healthy Tissues.

James T Paget, Joseph A Ward, Andrew R McKean

|Mar 26, 2022

CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanoma.

Galabina Bozhanova, Jehanne Hassan, Lizzie Appleton

|Mar 22, 2022

Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockade.

Emmanuel C Patin, Magnus T Dillon, Pablo Nenclares

|Mar 13, 2020

Inflammatory microenvironment remodelling by tumour cells after radiotherapy.

Martin McLaughlin, Emmanuel C Patin, Malin Pedersen

|Jan 26, 2018

Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues.

Aadil A Khan, James T Paget, Martin McLaughlin

Pageof 1

Frequent Collaborators

4 joint publications

Alan Melcher

4 joint publications

Kevin J Harrington

3 joint publications

Victoria Roulstone

3 joint publications

Emmanuel Christian Patin

3 joint publications

Malin Pedersen

2 joint publications

Aadil Khan

2 joint publications

James T Paget

2 joint publications

Joan N Kyula-Currie

1 joint publications

Martin Halle

1 joint publications

Jessica K R Boult

Frequent Collaborators

4 joint publications

Alan Melcher

4 joint publications

Kevin J Harrington

3 joint publications

Victoria Roulstone

3 joint publications

Emmanuel Christian Patin

Top Related Videos

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on : Jul 07, 2023

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on : Jun 02, 2021

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

See more related videos

Top Related Videos

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction

Published on : Jul 07, 2023

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Investigating Target Gene Function in a CD40 Agonistic Antibody-induced Colitis Model using CRISPR/Cas9-based Technologies

Published on : Jun 02, 2021

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on : Jan 07, 2019

See more related videos